 | • レポートコード：MRC23Q36023 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のフュージョントランススクリプトアッセイ市場について調査・分析し、世界のフュージョントランススクリプトアッセイ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フュージョントランススクリプトキット、PCR装置）、用途別セグメント分析（病院、がん研究施設、診断所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Illumina, Inc.、Merck Millipore、Hologic Inc.、Hologic Inc Bio-Rad Laboratories Inc.、Caris Life Sciences、SeraCare Life Sciences Inc.、QIAGENなどが含まれています。世界のフュージョントランススクリプトアッセイ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、フュージョントランススクリプトアッセイ市場規模を推定する際に考慮しました。本レポートは、フュージョントランススクリプトアッセイの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、フュージョントランススクリプトアッセイに関するビジネス上の意思決定に役立てることを目的としています。 ・フュージョントランススクリプトアッセイ市場の概要 - フュージョントランススクリプトアッセイのタイプ別セグメント - 世界のフュージョントランススクリプトアッセイ市場規模：タイプ別分析（フュージョントランススクリプトキット、PCR装置） - フュージョントランススクリプトアッセイの用途別セグメント - 世界のフュージョントランススクリプトアッセイ市場規模：用途別分析（病院、がん研究施設、診断所、その他） - 世界のフュージョントランススクリプトアッセイ市場規模予測（2018年-2029年） ・フュージョントランススクリプトアッセイ市場の成長トレンド - フュージョントランススクリプトアッセイの地域別市場規模（2018年-2029年） - フュージョントランススクリプトアッセイ市場ダイナミクス - フュージョントランススクリプトアッセイの業界動向 - フュージョントランススクリプトアッセイ市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：フュージョントランススクリプトキット、PCR装置 - 世界のフュージョントランススクリプトアッセイのタイプ別市場規模（2018年-2023年） - 世界のフュージョントランススクリプトアッセイのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、がん研究施設、診断所、その他 - 世界のフュージョントランススクリプトアッセイの用途別市場規模（2018年-2023年） - 世界のフュージョントランススクリプトアッセイの用途別市場規模（2024年-2029年） ・フュージョントランススクリプトアッセイの地域別市場規模 - 北米のフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - アメリカのフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - ヨーロッパのフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - アジア太平洋のフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - 中国のフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - 日本のフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - 韓国のフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - インドのフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - オーストラリアのフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - 中南米のフュージョントランススクリプトアッセイ市場規模（2018年-2029年） - 中東・アフリカのフュージョントランススクリプトアッセイ市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Illumina, Inc.、Merck Millipore、Hologic Inc.、Hologic Inc Bio-Rad Laboratories Inc.、Caris Life Sciences、SeraCare Life Sciences Inc.、QIAGEN ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Fusion Transcript Assays market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Fusion Transcript Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Fusion Transcript Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Fusion Transcript Assays in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Fusion Transcript Assays include Thermo Fisher Scientific, Illumina, Inc., Merck Millipore, Hologic Inc., Hologic Inc Bio-Rad Laboratories Inc., Caris Life Sciences, SeraCare Life Sciences Inc. and QIAGEN, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fusion Transcript Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fusion Transcript Assays.
The Fusion Transcript Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Fusion Transcript Assays market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fusion Transcript Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Illumina, Inc.
Merck Millipore
Hologic Inc.
Hologic Inc Bio-Rad Laboratories Inc.
Caris Life Sciences
SeraCare Life Sciences Inc.
QIAGEN
Segment by Type
Fusion Transcript Kits
PCR Devices
Segment by Application
Hospital
Cancer Research Center
Diagnostic Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fusion Transcript Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fusion Transcript Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fusion Transcript Kits
1.2.3 PCR Devices
1.3 Market by Application
1.3.1 Global Fusion Transcript Assays Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Cancer Research Center
1.3.4 Diagnostic Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fusion Transcript Assays Market Perspective (2018-2029)
2.2 Fusion Transcript Assays Growth Trends by Region
2.2.1 Global Fusion Transcript Assays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fusion Transcript Assays Historic Market Size by Region (2018-2023)
2.2.3 Fusion Transcript Assays Forecasted Market Size by Region (2024-2029)
2.3 Fusion Transcript Assays Market Dynamics
2.3.1 Fusion Transcript Assays Industry Trends
2.3.2 Fusion Transcript Assays Market Drivers
2.3.3 Fusion Transcript Assays Market Challenges
2.3.4 Fusion Transcript Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fusion Transcript Assays Players by Revenue
3.1.1 Global Top Fusion Transcript Assays Players by Revenue (2018-2023)
3.1.2 Global Fusion Transcript Assays Revenue Market Share by Players (2018-2023)
3.2 Global Fusion Transcript Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fusion Transcript Assays Revenue
3.4 Global Fusion Transcript Assays Market Concentration Ratio
3.4.1 Global Fusion Transcript Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fusion Transcript Assays Revenue in 2022
3.5 Fusion Transcript Assays Key Players Head office and Area Served
3.6 Key Players Fusion Transcript Assays Product Solution and Service
3.7 Date of Enter into Fusion Transcript Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fusion Transcript Assays Breakdown Data by Type
4.1 Global Fusion Transcript Assays Historic Market Size by Type (2018-2023)
4.2 Global Fusion Transcript Assays Forecasted Market Size by Type (2024-2029)
5 Fusion Transcript Assays Breakdown Data by Application
5.1 Global Fusion Transcript Assays Historic Market Size by Application (2018-2023)
5.2 Global Fusion Transcript Assays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fusion Transcript Assays Market Size (2018-2029)
6.2 North America Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Fusion Transcript Assays Market Size by Country (2018-2023)
6.4 North America Fusion Transcript Assays Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fusion Transcript Assays Market Size (2018-2029)
7.2 Europe Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Fusion Transcript Assays Market Size by Country (2018-2023)
7.4 Europe Fusion Transcript Assays Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fusion Transcript Assays Market Size (2018-2029)
8.2 Asia-Pacific Fusion Transcript Assays Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Fusion Transcript Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Fusion Transcript Assays Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fusion Transcript Assays Market Size (2018-2029)
9.2 Latin America Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Fusion Transcript Assays Market Size by Country (2018-2023)
9.4 Latin America Fusion Transcript Assays Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fusion Transcript Assays Market Size (2018-2029)
10.2 Middle East & Africa Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Fusion Transcript Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Fusion Transcript Assays Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Fusion Transcript Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Fusion Transcript Assays Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Detail
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Fusion Transcript Assays Introduction
11.2.4 Illumina, Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.2.5 Illumina, Inc. Recent Development
11.3 Merck Millipore
11.3.1 Merck Millipore Company Detail
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Fusion Transcript Assays Introduction
11.3.4 Merck Millipore Revenue in Fusion Transcript Assays Business (2018-2023)
11.3.5 Merck Millipore Recent Development
11.4 Hologic Inc.
11.4.1 Hologic Inc. Company Detail
11.4.2 Hologic Inc. Business Overview
11.4.3 Hologic Inc. Fusion Transcript Assays Introduction
11.4.4 Hologic Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.4.5 Hologic Inc. Recent Development
11.5 Hologic Inc Bio-Rad Laboratories Inc.
11.5.1 Hologic Inc Bio-Rad Laboratories Inc. Company Detail
11.5.2 Hologic Inc Bio-Rad Laboratories Inc. Business Overview
11.5.3 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Introduction
11.5.4 Hologic Inc Bio-Rad Laboratories Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.5.5 Hologic Inc Bio-Rad Laboratories Inc. Recent Development
11.6 Caris Life Sciences
11.6.1 Caris Life Sciences Company Detail
11.6.2 Caris Life Sciences Business Overview
11.6.3 Caris Life Sciences Fusion Transcript Assays Introduction
11.6.4 Caris Life Sciences Revenue in Fusion Transcript Assays Business (2018-2023)
11.6.5 Caris Life Sciences Recent Development
11.7 SeraCare Life Sciences Inc.
11.7.1 SeraCare Life Sciences Inc. Company Detail
11.7.2 SeraCare Life Sciences Inc. Business Overview
11.7.3 SeraCare Life Sciences Inc. Fusion Transcript Assays Introduction
11.7.4 SeraCare Life Sciences Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.7.5 SeraCare Life Sciences Inc. Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Detail
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Fusion Transcript Assays Introduction
11.8.4 QIAGEN Revenue in Fusion Transcript Assays Business (2018-2023)
11.8.5 QIAGEN Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details